Herman R J, Laverty W H
College of Medicine, University of Saskatchewan, Saskatoon.
Clin Invest Med. 1994 Aug;17(4):281-9.
Kernel density estimation was examined as an objective, nonparametric approach to the detection of polymorphic variation in distributions containing multiple complex data sets. Power curves were constructed for the kernel density estimate based on its ability to detect worked bimodality in stimulated distributions as a function of the distribution size, the fraction contained within a particular subdistribution, and the location of the mean of that subdistribution with respect to the mean of the overall distribution. Comparisons were then made between kernel density estimation and the Kolmogorov-Smirnov test of maximal differences. Results showed that kernel density estimation performed as well or better than the Kolmogorov-Smirnov test and offered a number of advantages, including identification of the frequency and placement of individual modes and antimodes. The Kolmogorov-Smirnov test, on the other hand, examined normality of a distribution rather than modality or inherent polymorphism, and the outcome was highly dependent on the subdistribution location and total distribution size. We conclude that kernel density estimation is an excellent method for analysis of polymorphic variation in drug metabolism.
核密度估计被视为一种客观的非参数方法,用于检测包含多个复杂数据集的分布中的多态性变异。基于核密度估计检测模拟分布中的双峰性的能力,构建了功率曲线,该能力是分布大小、特定子分布中所含部分的比例以及该子分布的均值相对于总体分布均值的位置的函数。然后对核密度估计与最大差异的柯尔莫哥洛夫-斯米尔诺夫检验进行了比较。结果表明,核密度估计的表现与柯尔莫哥洛夫-斯米尔诺夫检验相当或更好,并且具有许多优势,包括识别各个模态和反模态的频率及位置。另一方面,柯尔莫哥洛夫-斯米尔诺夫检验考察的是分布的正态性而非模态或内在多态性,其结果高度依赖于子分布位置和总分布大小。我们得出结论,核密度估计是分析药物代谢中多态性变异的一种优秀方法。